Alveus Therapeutics, Inc. — Form D

Alveus Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-14. The offering totals $110.7M, of which $56.9M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2026-01-14
• Form: D
• Accession: 0001231919-26-000051
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $110.7M
• Amount sold: $56.9M
• Remaining: $53.9M
• Investors: 17
• Date of first sale: 2025-12-22
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-569872

Issuer

• Name: Alveus Therapeutics, Inc.
• CIK: 0002075856
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 100 N. 18TH STREET, SUITE 1930, PHILADELPHIA, PA, 19103
• Phone: 215-419-7830

Officers, directors & promoters (9)

More

• CIK 2075856 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search